Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of A&G Pharmaceutical, Inc. patents

List of A&G Pharmaceutical, Inc. patents

List of Qumulo patents

List of Fastcap Systems Corporation patents

List of FlowCardia patents

List of SBIR/STTR awards granted to Accelerator Technology Corporation

List of NGOs in Fort Wayne, Indiana

Patents where

Current Assignee

Name

is

‌

A&G Pharmaceutical, Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7560095 Cancer specific monoclonal antibodies	Patent 7560095 was granted and assigned to A&G Pharmaceutical, Inc. on July, 2009 by the United States Patent and Trademark Office.		‌ A&G Pharmaceutical, Inc.		United States Patent and Trademark Office	7560095	July 14, 2009
	‌ US Patent 11555074 Monoclonal antibodies and conjugates against prostaglandin F2 receptor inhibitor and uses thereof	Patent 11555074 was granted and assigned to A&G Pharmaceutical, Inc. on January, 2023 by the United States Patent and Trademark Office.	‌ A&G Pharmaceutical, Inc.	‌ A&G Pharmaceutical, Inc.		United States Patent and Trademark Office	11555074	January 17, 2023
	‌ US Patent 7674460 Compositions and methods for restoring sensitivity to treatment with HER2 antagonists	Patent 7674460 was granted and assigned to A&G Pharmaceutical, Inc. on March, 2010 by the United States Patent and Trademark Office.		‌ A&G Pharmaceutical, Inc.		United States Patent and Trademark Office	7674460	March 9, 2010
	‌ US Patent 8088373 Autocrine growth factor receptor antibodies and methods	Patent 8088373 was granted and assigned to A&G Pharmaceutical, Inc. on January, 2012 by the United States Patent and Trademark Office.		‌ A&G Pharmaceutical, Inc.		United States Patent and Trademark Office	8088373	January 3, 2012
	‌ US Patent 7651854 Methods for increasing the proliferation of B cells	Patent 7651854 was granted and assigned to A&G Pharmaceutical, Inc. on January, 2010 by the United States Patent and Trademark Office.		‌ A&G Pharmaceutical, Inc.		United States Patent and Trademark Office	7651854	January 26, 2010
	‌ US Patent 7815906 Compositions and methods for restoring sensitivity to treatment with HER2 antagonists	Patent 7815906 was granted and assigned to A&G Pharmaceutical, Inc. on October, 2010 by the United States Patent and Trademark Office.		‌ A&G Pharmaceutical, Inc.		United States Patent and Trademark Office	7815906	October 19, 2010
	‌ US Patent 8007997 Methods and compositions for inhibiting the growth of hematopoietic malignant cells	Patent 8007997 was granted and assigned to A&G Pharmaceutical, Inc. on August, 2011 by the United States Patent and Trademark Office.		‌ A&G Pharmaceutical, Inc.		United States Patent and Trademark Office	8007997	August 30, 2011
	‌ US Patent 8911950 Methods and compositions for inhibiting the growth of hematopoietic malignant cells	Patent 8911950 was granted and assigned to A&G Pharmaceutical, Inc. on December, 2014 by the United States Patent and Trademark Office.		‌ A&G Pharmaceutical, Inc.		United States Patent and Trademark Office	8911950	December 16, 2014
	‌ US Patent 7411045 Autocrine growth factor receptor antibodies and methods	Patent 7411045 was granted and assigned to A&G Pharmaceutical, Inc. on August, 2008 by the United States Patent and Trademark Office.		‌ A&G Pharmaceutical, Inc.		United States Patent and Trademark Office	7411045	August 12, 2008
	‌ US Patent 8512960 88kDa tumorigenic growth factor and antagonists			‌ A&G Pharmaceutical, Inc.		United States Patent and Trademark Office	8512960	August 20, 2013
	‌ US Patent 6881548 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy	Patent 6881548 was granted and assigned to A&G Pharmaceutical, Inc. on April, 2005 by the United States Patent and Trademark Office.		‌ A&G Pharmaceutical, Inc.		United States Patent and Trademark Office	6881548	April 19, 2005

11 results

0 selected

11 results

0 selected